Cardiovascular diseases (CVD) impose a large worldwide burden, including direct medical expenditures and indirect productivity losses, emphasizing the importance of effective health resource allocation. Willingness-to-pay (WTP) studies provide vital information about public preferences for preventive and therapeutic interventions, ranging from lifestyle changes to advanced medical treatments. This review’s aim was to synthesize the current literature on WTP in the context of CVD prevention and management. Income, education, and family history all influence individuals’ investment in preventative methods, with preferences ranging greatly across intervention types. Structured lifestyle programs mostly attract those who have long-term goals regarding their health, whereas medical therapies are appealing to individuals seeking immediate benefits. The main limitations to the practical applications of WTP findings are issues such as hypothetical bias and socioeconomic inequities. Addressing these limitations may help to design more equitable and effective programs. Policymakers can use WTP data to construct cost-sharing models and tiered subsidies that would improve access and increase engagement with preventive health programs. To guarantee sustainability and representativeness, future research should concentrate more on diverse demographics, real-world transaction simulations, and interaction with current health systems. Incorporating WTP insights into healthcare planning has the potential to enhance CVD prevention outcomes and promote long-term, patient-centered approaches.
Amidi et al. (Wed,) studied this question.